Technology News and Research

RSS

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.

9 Jul 2010

Haemonetics settles patent infringement suit against STRADIS-MED

Haemonetics GmbH today announced settlement of its pending legal action against STRADIS-MED GmbH and its General Manager, Jochen Kirchner, for the infringement of two German utility models of Haemonetics (DE 200 10 825 U1 and DE 203 10 937 U1) related to Haemonetics' plasma technology.

9 Jul 2010

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.

9 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

VBA acquires BISNet software from ClearBenefits

Vantage Benefits Administrators (VBA) is proud to announce the acquisition of the BISNet software and all its Intellectual Property from ClearBenefits, Inc. to strategically enhance our Unified Point of Service administration offerings. BISNet, Inc., a fully owned subsidiary of Vantage Benefits Administrators, will reemerge as a world class benefits enrollment and administration system provider on July 15, 2010.

9 Jul 2010

iPierian announces closing of $22M Series B equity financing round

iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.

9 Jul 2010

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

ITelagen, a leading provider of Healthcare IT solutions, was selected by Christ Hospital to provide electronic health records (EHR) as part of an entire back-office solution that includes outsourced billing and unlimited IT support for their affiliate Canterbury Medical Associates.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

9 Jul 2010

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Roche Molecular Systems, Inc. announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States.

9 Jul 2010

Onda celebrates 2000th hydrophone shipment

Onda Corporation, the global leader in ultrasound measurements, celebrated the 2000th hydrophone shipment. The hallmark unit, a polymer-based HNP hydrophone, shipped to St. Jude's Medical where it is used to test the acoustic properties of their medical transducers in production.

8 Jul 2010

pSivida submits MAA for Iluvien to UK MHRA

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.

8 Jul 2010

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

PhotoMedex, Inc. announced that the Company has received from AMICO Group, its distributor in the Middle East, a multi-million dollar order to purchase XTRAC laser systems that will be installed in hospitals throughout the Kingdom of Saudi Arabia. The order includes customary terms and conditions, including advanced payments and letters of credit covering the purchase order. Delivery is expected to be in the third and fourth quarters of this year.

8 Jul 2010

Calithera Biosciences completes Series A financing totaling $40M

Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.

8 Jul 2010

WSBI, University of Colorado sign licensing agreement for TCISM targets

Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.

8 Jul 2010

Elsevier and Legacy Interactive release Top Doc iPhone app for medical students, practitioners

Elsevier, a world leader in health care, medical publishing and online solutions, and video game developer and publisher Legacy Interactive(R), announced today the release of Top Doc, an iPhone app that features medical content and quizzes designed to let medical students, residents and junior faculty practice and improve their visual diagnosis skills. Elsevier and Legacy Interactive(R) developed the app's interactive format to engage and challenge users with multiple elements.

8 Jul 2010

USF granted patent for cell transplantation procedure

The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.

8 Jul 2010

Health information technology still faces significant barriers to implementation: Survey

Hospitals understand the importance of health information technology (IT) and the benefits of its widespread adoption, yet as a field still face significant barriers to implementation according to a newly released survey of America's Most Wired hospitals and health systems.

8 Jul 2010

Biopharmaceutical Nanotechnology Scientific Forum to take place in Philadelphia between August 16-18

IQPC presents Biopharmaceutical Nanotechnology Scientific Forum taking place August 16-18 in Philadelphia, PA.

From IQPC Ltd 8 Jul 2010

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Researchers are using nanotechnology to develop a medical dressing which will detect and treat infection in wounds. Scientists at the University of Bath and the burns team at the Southwest UK Paediatric Burns Centre at Frenchay Hospital in Bristol are working together with teams across Europe and Australia to create an advanced wound dressing.

8 Jul 2010

Technology News and Research

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

Haemonetics settles patent infringement suit against STRADIS-MED

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

VBA acquires BISNet software from ClearBenefits

iPierian announces closing of $22M Series B equity financing round

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Onda celebrates 2000th hydrophone shipment

pSivida submits MAA for Iluvien to UK MHRA

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

Calithera Biosciences completes Series A financing totaling $40M

WSBI, University of Colorado sign licensing agreement for TCISM targets

Elsevier and Legacy Interactive release Top Doc iPhone app for medical students, practitioners

USF granted patent for cell transplantation procedure

Health information technology still faces significant barriers to implementation: Survey

Biopharmaceutical Nanotechnology Scientific Forum to take place in Philadelphia between August 16-18

Researchers use nanotechnology to develop advanced wound dressing to detect, treat infection

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News